ELEVATION OF MATRIX METALLOPROTEINASES 3 AND 9 IN CEREBROSPINAL FLUID AND BLOOD IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY

OBJECTIVETraumatic brain injury (TBI) causes an increase in matrix metalloproteinases (MMPs), which are associated with neuroinflammation, blood-brain barrier disruption, hemorrhage, and cell death. We hypothesized that patients with TBI have an increase in MMPs in ventricular cerebrospinal fluid (CSF) and plasma. METHODSPatients with TBI and a ventricular catheter were entered into the study. Samples of CSF and plasma were collected at the time of catheter placement and at 24 and 72 hours after admission. Seven TBI patients were entered into the study, with 6 having complete data for analysis. Only patients who had a known time of insult that fell within a 6-hour window from initial insult to ventriculostomy were accepted into the study. Control CSF came from ventricular fluid in patients undergoing shunt placement for normal pressure hydrocephalus. Both MMP-2 and MMP-9 were measured with gelatin zymography and MMP-3 with Western immunoblot. RESULTSWe found a significant elevation in the levels of the latent form of MMP-9 (92-kD) in the CSF obtained at the time of arrival (P < 0.05). Elevated levels of MMP-2 were detected in plasma at 72 hours, but not in the CSF. Using albumin from both CSF and blood, we calculated the MMP-9 index, which was significantly increased in the CSF, indicating endogenous MMP production. Western immunoblot showed elevated levels of MMP-3 in CSF at all times measured, whereas MMP-3 was not detected in the CSF of normal pressure hydrocephalus. CONCLUSIONWe show that MMPs are increased in the CSF of TBI patients. Although the number of patients was small, the results were robust and clearly demonstrated increases in MMP-3 and MMP-9 in ventricular CSF in TBI patients compared with controls. Although these preliminary results will need to be replicated, we propose that MMPs may be important in blood-brain barrier opening and hemorrhage secondary to brain injury in patients.

[1]  J. Montaner,et al.  Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases , 2008, Intensive Care Medicine.

[2]  S. Taheri,et al.  Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-α in the Rat , 2007, Journal of Pharmacology and Experimental Therapeutics.

[3]  J. Noth,et al.  Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury , 2007, BMC neurology.

[4]  G. Rosenberg,et al.  Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation , 2006, Neurobiology of Disease.

[5]  E. Lo,et al.  Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke , 2006, Stroke.

[6]  V. Yong,et al.  Metalloproteinases: Mediators of Pathology and Regeneration in the CNS , 2005, Nature Reviews Neuroscience.

[7]  H. J. Kim,et al.  Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis , 2005, Experimental Neurology.

[8]  J. Laínez,et al.  Molecular Signatures of Vascular Injury Are Associated With Early Growth of Intracerebral Hemorrhage , 2005, Stroke.

[9]  M. Fujii,et al.  Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. , 2004, Journal of neurotrauma.

[10]  J. Adair,et al.  Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer Disease , 2004, Stroke.

[11]  J. Arenillas,et al.  Temporal Profile of Matrix Metalloproteinases and Their Inhibitors After Spontaneous Intracerebral Hemorrhage: Relationship to Clinical and Radiological Outcome , 2004, Stroke.

[12]  Michael Gaetz,et al.  The neurophysiology of brain injury , 2004, Clinical Neurophysiology.

[13]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[14]  C. Molina,et al.  Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. , 2003, Journal of neurosurgery.

[15]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[16]  H. Stam,et al.  Traumatic brain injury: classification of initial severity and determination of functional outcome , 2003, Disability and rehabilitation.

[17]  G. Rosenberg.  Matrix Metalloproteinases and Neuroinflammation in Multiple Sclerosis , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[18]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[19]  E. Lo,et al.  Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases , 2002, Journal of neuroscience research.

[20]  M. Trojano,et al.  Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis , 2002, Multiple sclerosis.

[21]  G. Rosenberg,et al.  Stromelysin-1 and gelatinase A are upregulated before TNF-α in LPS-stimulated neuroinflammation , 2002, Brain Research.

[22]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[23]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[24]  L. Kappos,et al.  Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis , 2001, Brain Research Reviews.

[25]  V. Wee Yong,et al.  Metalloproteinases in biology and pathology of the nervous system , 2001, Nature Reviews Neuroscience.

[26]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury , 2000, The Journal of Neuroscience.

[27]  G. Holländer,et al.  Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. Fujimura,et al.  Overexpression of Copper and Zinc Superoxide Dismutase in Transgenic Mice Prevents the Induction and Activation of Matrix Metalloproteinases after Cold Injury-Induced Brain Trauma , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  P. Gottschall,et al.  Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. , 1996, Neuroimmunomodulation.

[30]  G. Rosenberg.  Matrix metalloproteinases in brain injury. , 1995, Journal of neurotrauma.

[31]  J. Langlois,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths , 2006 .

[32]  Y. Katayama,et al.  Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. , 2006, Acta neurochirurgica. Supplement.

[33]  A. Strongin,et al.  Membrane Type-1 Matrix Metalloproteinase Functions as a Proprotein Self-convertase EXPRESSION OF THE LATENT ZYMOGEN IN PICHIA PASTORIS , AUTOLYTIC ACTIVATION, AND THE PEPTIDE SEQUENCE OF THE CLEAVAGE FORMS* , 2003 .

[34]  G. Rosenberg,et al.  Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. , 2002, Brain research.

[35]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.